Watchlist Price Alert

CRISPR Therapeutics AG (CRSP)

NASDAQ: CRSP · Real-Time Price · USD

44.14

2.56 (6.16%)

At close: Jun 17, 2025, 10:12 AM

CRISPR Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-366.25M	-153.61M	-650.17M	377.66M	-348.87M	66.86M	-164.98M	-68.36M	-23.2M
Depreciation & Amortization	19.26M	19.84M	24.17M	17.95M	9.18M	4.72M	3.52M	3.02M	925K
Stock-Based Compensation	86.57M	81.03M	97.95M	102.39M	66.02M	44.06M	34.98M	18.87M	10.84M
Other Working Capital	-18.73M	3.33M	14.38M	27.02M	33.48M	-48.42M	-1M	-21.24M	1.83M
Other Non-Cash Items	-38.62M	-14.04M	12.47M	14.11M	1.86M	-10.53M	15.41M	1.75M	8.05M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	4.28M	n/a	-53.71M
Change in Working Capital	156.27M	-193.59M	19.84M	26.86M	33.44M	-48.43M	10.55M	-25.39M	1.78M
Operating Cash Flow	-142.77M	-260.38M	-495.74M	538.97M	-238.37M	56.68M	-96.24M	-70.1M	-55.31M
Capital Expenditures	-1.9M	-11.97M	-37.19M	-81.7M	-18.36M	-6.68M	-2.77M	-7.81M	-3.02M
Cash Acquisitions	n/a	n/a	221.47M	953.73M	522.81M	8.01M	n/a	n/a	-100K
Purchase of Investments	-1.46B	-1.07B	-1.42B	-1.51B	-594M	n/a	n/a	-500K	-100K
Sales Maturities Of Investments	1.21B	1.45B	1.2B	555.6M	71.19M	n/a	n/a	n/a	n/a
Other Investing Acitivies	-23.18M	-2.5M	-221.47M	-953.73M	-522.81M	8.01M	n/a	-500K	35M
Investing Cash Flow	-280.48M	374.65M	-258.65M	-1.04B	-541.17M	1.32M	-2.77M	-8.31M	31.88M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	35.01M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	-57K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	29.94M	37.62M	37.68M	33.86M	15.96M	8.94M	2.61M	-1.78M
Financial Cash Flow	331.98M	62.66M	38.59M	250.94M	1.02B	430.98M	315.93M	2.61M	183.22M
Net Cash Flow	-91.29M	177.01M	-715.88M	-245.52M	236.66M	489M	216.9M	-75.76M	159.56M
Free Cash Flow	-144.68M	-272.35M	-532.93M	457.27M	-256.72M	49.99M	-99.01M	-77.91M	-58.33M